Andersons pediatric cardiology 2088

clinicaldiagnosisinthefirstyearoflife.Mol
Syndromol.2011;1:282–289.
92.PierpointME,MagoulasPL,AdiS,etal.Cardiofacio-cutaneoussyndrome:clinicalfeatures,
diagnosis,andmanagementguidelines.
Pediatrics.2014;134:1149–1162.
93.RauenKA.HRASandthecostellosyndrome.
ClinGenet.2007;71:101–108.
94.CalcagniG,BabanA,LepriFR,etal.Congenital
heartdefectsinnoonansyndromeandRIT1
mutation.GenetMed.2016;18:1320.
95.Ruiz-PerezVL,GoodshipJA.Ellis-vanCreveld
syndromeandWeyersacrodentaldysostosisare
causedbycilia-mediateddiminishedresponseto
hedgehogligands.AmJMedGenet.
2009;151C:341–351.
96.D'AsdiaC,TorrenteI,ConsoliF,etal.Noveland
recurrentEVCandEVC2mutationsinellis-van
CreveldandWeyersacrofacialdysostosis.EurJ
MedGenet.2013;56:80–87.
97.DigilioMC,MarinoB,GiannottiA,etal.The
atrioventricularcanaldefectisthecongenital
heartdiseaseconnectingshort-ribpolydactyly
andoral-facial-digitalsyndromes.AmJMed
Genet.1997;68:110–112.
98.PeoplesWM,MollerJH,EdwardsJE.
Polysplenia:areviewof146cases.Pediatr


Cardiol.1983;4:129–138.
99.ChowdhuryD,WilliamsKB,ChidekelA,etal.
Managementofcongenitalheartdisease

associatedwithellis-vanCreveldshort-rib
thoracicdysplasia.JPediatr.2017;191:145–
151.
100.Caparros-MartinJA,DeLucaA,CartaultF,etal.
SpecificvariantsinWDR35causeadistinctive
formofellis-vanCreveldsyndromeby
disruptingtherecruitmentoftheEvCcomplex
andSMOintothecilium.HumMolGenet.
2015;24:4126–4137.
101.NicetaM,MargiottiK,DigilioMC,etal.
BiallelicmutationsinDYNCH2LI1arearare
causeofellis-vanCreveldsyndrome.Clin
Genet.2017[(online)].
102.PhilipN,MeineckeP,DavidA,etal.Kabuki
make-up(niikawa-kuroki)syndrome:astudyof
16non-Japanesecases.ClinDysmorphol.
1992;1:63–77.
103.KawameH,HannibalMC,HudginsL,etal.
Phenotypicspectrumandmanagementissuesin
kabukisyndrome.JPediatr.1999;134:480–485.
104.Schrander-StumpelC,MeineckeP,WilsonG,et
al.TheKabuki(niikawa-kuroki)syndrome:
furtherdelineationofthephenotypein29nonJapanesepatients.EurJPediatr.1994;153:438–


445.
105.DigilioMC,MarinoB,ToscanoA,etal.
CongenitalheartdefectsinKabukisyndrome.
AmJMedGenet.2001;100:269–274.
106.DigilioMC,GnazzoM,LepriF,etal.Congenital

heartdefectsinmolecularlyprovenKabuki
syndromepatients.AmJMedGenetA.
2017;173:2912–2922.
107.ShoneJD,SellersRD,AndersonRC,etal.The
developmentalcomplexofparachutemitral
valve,supravalvularringoftheleftatrium,
subaorticstenosisandcoarctationoftheaorta.
AmJCardiol.1963;11:714–725.
108.NgSB,BuckinghamKJ,HannibalMC,etal.
ExomesequencingidentifiesMLL2mutations
asacauseofKabukisyndrome.NatGenet.
2010;42:790–793.
109.LedererD,GrisartB,DigilioMC,etal.Deletion
ofKDM6A,ahistonedemethylaseinteracting
withMLL2,inthreepatientswithKabuki
syndrome.AmJHumGenet.2012;90:119–124.
110.BögershausenN,TsaiI-C,PohlE,etal.RAP1mediatedMEK/ERKpathwaydefectsinKabuki
syndrome.JClinInvest.2015;125:3585–3599.
111.LangeL,PagnamentaAT,LiseS,etal.Ade
novoframeshiftinHNRNPKcausingakabukilikesyndromewithnodularheterotopia.Clin